Free Trial

Janux Therapeutics (JANX) News Today

→ Write this ticker symbol down… (From StocksToTrade) (Ad)
Free JANX Stock Alerts
$44.16
+1.57 (+3.69%)
(As of 06/7/2024 08:52 PM ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends
June 8 at 1:30 AM | americanbankingnews.com
Janux Therapeutics (NASDAQ:JANX) Shares Gap Down Following Insider Selling
June 7 at 4:14 AM | americanbankingnews.com
Janux Therapeutics, Inc. (NASDAQ:JANX) CFO Tighe Reardon Sells 822,721 Shares
June 7 at 4:14 AM | americanbankingnews.com
Ventures Xi L.P. Avalon Sells 677,279 Shares of Janux Therapeutics, Inc. (NASDAQ:JANX) Stock
June 6, 2024 | americanbankingnews.com
Janux Therapeutics (NASDAQ:JANX) Shares Down 7%
June 6, 2024 | americanbankingnews.com
Janux Therapeutics, Inc. (NASDAQ:JANX) Director Jay Lichter Sells 1,500,000 Shares of Stock
June 6, 2024 | insidertrades.com
Janux Therapeutics, Inc. (NASDAQ:JANX) Major Shareholder Sells $37,081,025.25 in Stock
June 5, 2024 | marketbeat.com
Janux Therapeutics, Inc. (NASDAQ:JANX) Major Shareholder Ventures Xi L.P. Avalon Sells 677,279 Shares
Janux Therapeutics, Inc. (NASDAQ:JANX - Get Free Report) major shareholder Ventures Xi L.P. Avalon sold 677,279 shares of the stock in a transaction on Monday, June 3rd. The shares were sold at an average price of $54.75, for a total value of $37,081,025.25. Following the completion of the sale, the insider now directly owns 3,271,216 shares of the company's stock, valued at $179,099,076. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Large shareholders that own more than 10% of a company's shares are required to disclose their sales and purchases with the SEC.
June 4, 2024 | marketbeat.com
Janux Therapeutics (NASDAQ:JANX) Stock Price Down 7%
Janux Therapeutics (NASDAQ:JANX) Trading Down 7%
June 4, 2024 | marketbeat.com
51,548 Shares in Janux Therapeutics, Inc. (NASDAQ:JANX) Acquired by Janney Montgomery Scott LLC
Janney Montgomery Scott LLC purchased a new stake in shares of Janux Therapeutics, Inc. (NASDAQ:JANX - Free Report) during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm purchased 51,548 shares of the company's stock, valued at approx
June 4, 2024 | americanbankingnews.com
Janux Therapeutics, Inc. (NASDAQ:JANX) Given Average Rating of "Moderate Buy" by Analysts
June 4, 2024 | marketbeat.com
Janux Therapeutics, Inc. (NASDAQ:JANX) Receives Average Recommendation of "Moderate Buy" from Brokerages
Shares of Janux Therapeutics, Inc. (NASDAQ:JANX - Get Free Report) have been assigned an average rating of "Moderate Buy" from the eight analysts that are covering the company, MarketBeat Ratings reports. One research analyst has rated the stock with a hold rating and seven have given a buy rating
June 2, 2024 | americanbankingnews.com
Janux Therapeutics (NASDAQ:JANX) Trading Up 5%
May 31, 2024 | americanbankingnews.com
Janux Therapeutics (NASDAQ:JANX) Coverage Initiated by Analysts at Scotiabank
May 14, 2024 | marketbeat.com
Janux Therapeutics (NASDAQ:JANX) Trading Down 3.1%
Janux Therapeutics (NASDAQ:JANX) Shares Down 3.1%
May 13, 2024 | markets.businessinsider.com
Analysts Offer Insights on Healthcare Companies: Valneva (VALN), Janux Therapeutics Inc (JANX) and Kymera Therapeutics (KYMR)
May 13, 2024 | markets.businessinsider.com
Analyst Ratings For Janux Therapeutics
May 13, 2024 | marketbeat.com
Janux Therapeutics (NASDAQ:JANX) Price Target Raised to $63.00 at HC Wainwright
HC Wainwright raised their price target on Janux Therapeutics from $50.00 to $63.00 and gave the stock a "buy" rating in a research note on Monday.
May 10, 2024 | marketbeat.com
Q2 2024 EPS Estimates for Janux Therapeutics, Inc. Cut by William Blair (NASDAQ:JANX)
Janux Therapeutics, Inc. (NASDAQ:JANX - Free Report) - Stock analysts at William Blair reduced their Q2 2024 earnings estimates for shares of Janux Therapeutics in a research note issued on Tuesday, May 7th. William Blair analyst M. Phipps now expects that the company will earn ($0.21) per share
May 9, 2024 | marketbeat.com
Janux Therapeutics (NASDAQ:JANX) Given "Overweight" Rating at Cantor Fitzgerald
Cantor Fitzgerald reissued an "overweight" rating and issued a $100.00 price objective on shares of Janux Therapeutics in a research note on Thursday.
May 8, 2024 | marketbeat.com
Janux Therapeutics (NASDAQ:JANX) Shares Down 11.5%
Janux Therapeutics (NASDAQ:JANX) Stock Price Down 11.5%
May 8, 2024 | benzinga.com
Janux Therapeutics Options Trading: A Deep Dive into Market Sentiment
May 8, 2024 | finance.yahoo.com
Janux Therapeutics Reports Narrower Q1 Loss, Misses Revenue Estimates
May 7, 2024 | businesswire.com
Janux Therapeutics Reports First Quarter 2024 Financial Results and Business Highlights
May 6, 2024 | marketbeat.com
Janux Therapeutics (NASDAQ:JANX) Shares Gap Down to $64.78
Janux Therapeutics (NASDAQ:JANX) Shares Gap Down to $64.78
May 2, 2024 | msn.com
Janux Therapeutics gains amid renewed takeover speculation
May 2, 2024 | marketbeat.com
Janux Therapeutics (NASDAQ:JANX) Sets New 12-Month High at $64.79
Janux Therapeutics (NASDAQ:JANX) Hits New 12-Month High at $64.79
April 30, 2024 | finance.yahoo.com
Here's What Could Help Janux Therapeutics (JANX) Maintain Its Recent Price Strength
April 29, 2024 | marketbeat.com
Janux Therapeutics (NASDAQ:JANX) Shares Up 11.7%
Janux Therapeutics (NASDAQ:JANX) Trading 11.7% Higher
April 28, 2024 | marketbeat.com
Allspring Global Investments Holdings LLC Acquires 25,105 Shares of Janux Therapeutics, Inc. (NASDAQ:JANX)
Allspring Global Investments Holdings LLC boosted its holdings in shares of Janux Therapeutics, Inc. (NASDAQ:JANX - Free Report) by 2,166.1% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 26,264 shares of the company's
April 24, 2024 | marketbeat.com
Cerity Partners LLC Makes New $654,000 Investment in Janux Therapeutics, Inc. (NASDAQ:JANX)
Cerity Partners LLC purchased a new stake in Janux Therapeutics, Inc. (NASDAQ:JANX - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 60,933 shares of the company's stock, valued at approxima
April 17, 2024 | marketbeat.com
Janux Therapeutics (NASDAQ:JANX) Shares Down 4.1%
Janux Therapeutics (NASDAQ:JANX) Stock Price Down 4.1%
April 17, 2024 | investorplace.com
Take the Money and Run: 3 Overbought Stocks to Sell ASAP
April 17, 2024 | nasdaq.com
Validea Detailed Fundamental Analysis - JANX
April 16, 2024 | msn.com
JonesTrading Initiates Coverage of Janux Therapeutics (JANX) with Buy Recommendation
April 16, 2024 | msn.com
Janux a new buy at Jones on lead assets for solid tumors
April 16, 2024 | investorplace.com
These 3 Biotech Stocks Are Up 269% in 2024. Is There More to Come?
April 16, 2024 | benzinga.com
A Glimpse Into The Expert Outlook On Janux Therapeutics Through 6 Analysts
April 15, 2024 | marketbeat.com
Janux Therapeutics (NASDAQ:JANX) Shares Gap Down to $52.65
Janux Therapeutics (NASDAQ:JANX) Shares Gap Down to $52.65
April 12, 2024 | fool.com
Why Janux Therapeutics Stock Is Crushing It This Week
April 11, 2024 | theglobeandmail.com
Stocks See Continued Pressure as Bond Yields Climb
April 11, 2024 | benzinga.com
Why Is Cancer-Focused Janux Therapeutics Stock Trading Higher On Thursday?
April 11, 2024 | finance.yahoo.com
Biotech Stocks Heat Up As Arvinas Scores Novartis Licensing Pact, Janux Reportedly Explores Options
April 11, 2024 | investors.com
Biotech Stocks Heat Up As Arvinas Scores Novartis Licensing Pact, Janux Reportedly Explores Options
April 10, 2024 | fool.com
Why Janux Therapeutics Stock Soared as the Market Sagged Today
April 10, 2024 | marketbeat.com
Janux Therapeutics (NASDAQ:JANX) Sees Unusually-High Trading Volume
Janux Therapeutics (NASDAQ:JANX) Sees Strong Trading Volume
April 10, 2024 | msn.com
Janux Therapeutics surges amid report of takeover interest
April 10, 2024 | marketbeat.com
Trading was temporarily halted for "JANX" at 01:04 PM with a stated reason of "LULD pause."
April 8, 2024 | marketbeat.com
Janux Therapeutics (NASDAQ:JANX) Stock Price Up 6.9%
Janux Therapeutics (NASDAQ:JANX) Trading 6.9% Higher
April 5, 2024 | nasdaq.com
Commit To Purchase Janux Therapeutics At $25, Earn 26.5% Annualized Using Options
April 5, 2024 | morningstar.com
Janux Therapeutics Inc Ordinary Shares JANX
Get Janux Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for JANX and its competitors with MarketBeat's FREE daily newsletter.

Top 5 AI Stocks to Buy for 2024 (Ad)

The electric vehicle boom is accelerating – and fast.

Click to View The 5 Best AI Stocks to Invest In

JANX Media Mentions By Week

JANX Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

JANX
News Sentiment
▼
0.26

0.76
▲
Average
Medical
News Sentiment

JANX News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

JANX Articles
This Week
▼
14

2
▲
JANX Articles
Average Week

Get Janux Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for JANX and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

Related Companies:
Headlines Tools:
This page (NASDAQ:JANX) was last updated on 6/10/2024 by MarketBeat.com Staff

From Our Partners
Write this ticker symbol down…
A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...
StocksToTrade | Sponsored
It's time to ween off Chinese lithium!
As the lithium rush continues, this small-cap NASDAQ-traded company may be one of the brightest and most promi...
Smallcaps Daily | Sponsored
Top 5 Tech Stocks to Buy for 2024
The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...
Daily Market Alerts | Sponsored
Top 5 AI Stocks to Buy for 2024
The electric vehicle boom is accelerating – and fast.
Market Moving Trends | Sponsored
No Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for Free
Optimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...
Hedgeye | Sponsored
The Only Energy Play You Should Be Looking At
Open AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...
Wealthpin Pro | Sponsored
You won't believe what Citigroup just did to it's depositors
The FEDNOW Biden Dollar ends cash in a matter of WEEKS Stumbling Biden's dollar next phases begins Oct 21st...
American Alternative | Sponsored
RSVP: Charles Payne’s Cash Flow Workshop
Did you know you could "cash flow" the stocks in your portfolio? Without selling a single share of stock? ...
Unstoppable Prosperity | Sponsored